Symvess

acellular tissue engineered vessel-tyod

Approval

ApplicationBLA 125812
Approval dateDec 19, 2024
Approval year2024
SponsorHumacyte Global, Inc

FDA-approved use

use in adults as a vascular conduit for extremity arterial injury when urgent revascularization is needed to avoid imminent limb loss, and autologous vein graft is not feasible

Approval package

Query with Claude

The fda-analyst skill answers natural-language questions about this approval by fetching the relevant FDA review PDFs at query time.

git clone https://github.com/cbetz/trove
cp -r trove/skills/fda-analyst ~/.claude/skills/

Example prompts for Symvess: